Change text size  A -  A +   Text Only Site

Call our support line on 1800 111 709

LATEST NEWS ON MD RESEARCH

Researchers around the world are currently working on Macular Degeneration (MD) to find reasons for this disease and the answers needed. There are many ongoing clinical trials and the MD Foundation is proud of the many brilliant and dedicated Australian researchers who form part of this international team. Click here for a summary of this research.

RESEARCH AND REPORTS

There is ongoing research into Macular Degeneration both in Australia and around the world. The MD Foundation provides access to research reports for the MD Community to review and learn more about the disease. It is important to note however, that some research studies are more robust that others, and that there are differing opinions amongst the medical community about the validity of some of the research.


 

RISK FACTORS

 

Age, family history and smoking are the only proven risk factors for MD, with smoking being the only modifiable risk factor.

 

     

     

SUPPLEMENTS

 

  • Clinical trials conducted in the United States, titled The Age-Related Eye Disease Study (AREDS) have found that antioxidants and zinc could help to slow the progression of age related macular degeneration (AMD), among people with intermediate and late stages of MD.

     

  • A review of eight randomised trials comparing antioxidant vitamin or mineral supplementation (alone or in combination) to a control intervention in people conducted by the Cochrane Collaboration.
NUTRITION AND DIET

 

Please consult your health care professional before making any changes to your diet or lifestyle. Some foods and/or supplements can have an adverse effect on individual health conditions or drug regimes.

WET MD TREATMENTS

 

The following papers provide evidence regarding the extent of success about various treatments Wet MD available in Australia.

CATARACT AND MD

 

OTHER DISEASES AND MD

  • Macular Degeneration and Heart Disease
    Researchers at the University of Sydney have conducted a study which suggests that the risk of dying from cardiovascular conditions is at least doubled in people with AMD.
    Read the Summary


    Read the Detailed Study

 

CURRENT CLINICAL TRIALS

 

 

 

 

  • U.S. scientists have begun a clinical trial which involves surgically implanting a miniature telescope in the eyes of people with end-stage age-related macular degeneration.
RECENT RESEARCH DEVELOPMENTS

 

 

  • The UK National Library for Health released an AMD Annual Evidence Update in 2008. This update presents a collection of evidence on MD from research conducted from February 2007-May 2008. The main areas of research include: Epidemiology, Genetics, Retinal imaging for diagnosis, Therapeutic intervention: anti VEGF therapy, Surgical intervention: macular translocation and transplantation, Low vision aids and AMD and Living with AMD.

 

  • The Lions Eye Institute in Perth has recently released some exciting developments for the use of gene therapy and wet MD. Scientists have been able to restore vision in dogs suffering from Lebers congential amaurosis. Although this disease is different to MD they aim adapt the knowledge learnt from these findings into human trials for wet MD. This research is still in its early stages and Phase I human trials will commence in November 2009. Contact the Lions Eye Institute for further information on participation in the study.

 

 

  • A recently published study in Australia studied red meat and chicken consumption and its association with Age-related Macular Degeneration. The results from this study suggest that different meats may differently affect AMD risk and may be a target for lifestyle modification. Please note that this is the first study of its kind worldwide and the quantity of meat consumption is very large.

 

 

SOCIAL AND ECONOMIC IMPACTS

 

 

  • The first ever qualitative research on patient perspectives on quality of life with AMD. Patients report the anguish of delayed diagnosis, slow referrals and poor access to the latest treatments. Europe - AMD Alliance international.

 

OTHER RELEVANT AUSTRALIAN PUBLICATIONS

 

 

LINKS TO OTHER RELEVANT ORGANISATIONS

 

 

Top